TS
RVMDW icon

Thomas Steyer’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Thomas Steyer’s Portfolio RVMDW Stock Details RVMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Hold
120,085
– – 0.01% 77
2026
Q1 		$209K Hold
120,085
– – ﹤0.01% 141
2025
Q4 		$113K Hold
120,085
– – ﹤0.01% 144
2025
Q3 		$36K Hold
120,085
– – ﹤0.01% 141
2025
Q2 		$32.4K Hold
120,085
– – ﹤0.01% 143
2025
Q1 		$4.56K Hold
120,085
– – ﹤0.01% 146
2024
Q4 		$19.4K Hold
120,085
– – ﹤0.01% 151
2024
Q3 		$16.8K Hold
120,085
– – ﹤0.01% 159
2024
Q2 		$8.56K Hold
120,085
– – ﹤0.01% 163
2024
Q1 		$19.2K Hold
120,085
– – ﹤0.01% 170
2023
Q4 		$39.6K Buy
+120,085
New +$53.6K ﹤0.01% 143

Other funds holding RVMDW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Thomas Steyer's RVMDW Position: Q2 2026 in Review

Thomas Steyer held its Revolution Medicines Inc Warrant (RVMDW) position steady in Q2 2026 at 120,085 shares worth $1.13M. The position accounts for 0.01% of the portfolio, ranked #77.

Thomas Steyer first reported a position in RVMDW in Q4 2023 and has held it in 11 quarters since. 22 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

  • Thomas Steyer held 120,085 shares of Revolution Medicines Inc Warrant worth $1.13M as of Q2 2026.
  • Thomas Steyer left its Revolution Medicines Inc Warrant share count unchanged in Q2 2026.
  • Revolution Medicines Inc Warrant made up 0.01% of Thomas Steyer's portfolio in Q2 2026, its #77 holding.
  • Thomas Steyer first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 11 quarters since.
  • 22 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.